نتایج جستجو برای: hbsag mutation

تعداد نتایج: 296137  

Journal: :Vaccine 1999
M V Chengalvala R A Bhat B M Bhat S K Vernon M D Lubeck

The currently marketed hepatitis B vaccines in the U.S. are based on the recombinant major hepatitis B surface antigen (HBsAg) of hepatitis B virus. Although a large majority of individuals develop protective immunity to HBV-induced disease after three immunizations, routinely a small but a significant percentage of the human population does not respond well to these vaccines. In this report, w...

Journal: :Journal of immunology 2000
R Schirmbeck J Wild D Stober H E Blum F V Chisari M Geissler J Reimann

Different protein- or DNA-based vaccination techniques are available that prime potent humoral and cellular, T1 or T2 immune responses to the hepatitis B surface Ag (HBsAg) in mice. T1 and T2 are immune responses with isotype profile indicating Th1 and Th2 immunoregulation. We tested whether HBsAg-specific immune responses can be established in transgenic mice that express HBsAg in the liver (H...

Journal: :Chinese medical journal 2016
Xia-Xia Zhang Min-Ran Li Hong-Li Xi Ying Cao Ren-Wen Zhang Yu Zhang Xiao-Yuan Xu

BACKGROUND The ultimate goal of hepatitis B treatment is hepatitis B surface antigen (HBsAg) seroclearance. Several factors have been suggested to be associated with the rate of HBsAg reduction in antiviral-naive or lamivudine therapy cohorts. However, there are few studies evaluating the factors during long-term entecavir (ETV) therapy. In the present study, we aimed to evaluate the factors to...

Journal: :Antiviral therapy 2010
Sheikh Mohammad Fazle Akbar Osamu Yoshida Shiyi Chen Aguilar Julio Cesar Masanori Abe Bunzo Matsuura Yoichi Hiasa Morikazu Onji

BACKGROUND Commercially available prophylactic vaccines containing hepatitis B surface antigen (HBsAg), which are used to prevent HBV infections, are not as effective as a therapeutic immune modulator for treating patients with chronic hepatitis B (CHB). In this study, the immunogenicity of dendritic cells (DC) loaded with both HBsAg and hepatitis B core antigen (HBcAg) was tested in HBV transg...

Journal: :Hepatology 2011
Yun-Fan Liaw

This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline during the natural course of a chronic HBV infection; they are lowest in the inactive phase, which is ...

Journal: :Infection and immunity 1975
G R Irwin A M Allen W H Bancroft J J Karwacki H L Brown R H Pinkerton M Willhight F H Top

A survey of hepatitis B patients, asymptomatic hepatitis B antigen (HBsAg) carriers, and control subjects was conducted to determine the relationship between antigenemia and antigen excretion in saliva, urine, and stool. Radioimmunoassay was used to detect HBsAg. Specificity-confirmed HBsAg was detected in the saliva of 6 (30%) of 20 antigenemic patients, 1 (5%) of 20 nonantigenemic patients, 1...

Journal: :Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2006
Geraldine Kaminski Adel Alnaqdy Intesar Al-Belushi Jameel Nograles Said H Al-Dhahry

OBJECTIVES The aim of this study was to determine the prevalence of hepatitis B surface antigen (HBsAg), hepatitis B core antibodies (anti-HBc) and hepatitis B virus (HBV) DNA among a selected group of Omani blood donors. MATERIALS AND METHODS Two hundred HBsAg-negative donors were screened for anti-HBc. Those found to be positive were investigated for HBV DNA by polymerase chain reaction. HB...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1977
W T London J S Drew

Patients undergoing treatment at a community-based renal dialysis clinic were monitored monthly for hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs). Of 160 patients who began treatment HBsAg(-)/anti-HBs(-), 77 subsequently became HBsAg(+). Once HBsAg(+), males were more likely to remain HBsAg(+) indefinitely, whereas females were more likely to convert to HBsAg(-) and devel...

Journal: :Antiviral research 2012
Valentina Svicher Valeria Cento Martina Bernassola Maria Neumann-Fraune Formijn Van Hemert Mengjie Chen Romina Salpini Chang Liu Roberta Longo Michela Visca Sara Romano Valeria Micheli Ada Bertoli Caterina Gori Francesca Ceccherini-Silberstein Cesare Sarrecchia Massimo Andreoni Mario Angelico Antonella Ursitti Alberto Spanò Jing Maria Zhang Jens Verheyen Giuseppina Cappiello Carlo Federico Perno

Occult HBV infection (OBI) is a threat for the safety of blood-supply, and has been associated with the onset of HBV-related hepatocellular carcinoma and lymphomagenesis. Nevertheless, genetic markers in HBsAg (particularly in D-genotype, the most common in Europe) significantly associated with OBI in vivo are missing. Thus, the goal of this study is to define: (i) prevalence and clinical profi...

2017
Chao-Wei Hsu Kung-Hao Liang Chih-Lang Lin Tong-Hong Wang Chau-Ting Yeh

BACKGROUND The concentrations of hepatitis B virus (HBV) DNA and surface antigen (HBsAg) are two critical virological variables to be monitored in chronic hepatitis B. HBsAg is derived from the HBV genome. Thus, higher HBV-DNA concentrations should implicate higher HBsAg levels. Nevertheless, the two variables do not manifest a simple linear relationship due to elusive host factor involvements....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید